ATE480621T1 - Organische anionentransporter-proteine (oatp/lst) und ihre dna - Google Patents

Organische anionentransporter-proteine (oatp/lst) und ihre dna

Info

Publication number
ATE480621T1
ATE480621T1 AT03708492T AT03708492T ATE480621T1 AT E480621 T1 ATE480621 T1 AT E480621T1 AT 03708492 T AT03708492 T AT 03708492T AT 03708492 T AT03708492 T AT 03708492T AT E480621 T1 ATE480621 T1 AT E480621T1
Authority
AT
Austria
Prior art keywords
proteins
compounds
screening
affect
oatp
Prior art date
Application number
AT03708492T
Other languages
English (en)
Inventor
Atsushi Nakanishi
Yukiko Hikichi
Yumiko Uno
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE480621T1 publication Critical patent/ATE480621T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT03708492T 2002-03-06 2003-03-05 Organische anionentransporter-proteine (oatp/lst) und ihre dna ATE480621T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2002061133 2002-03-06
JP2002098852 2002-04-01
JP2002184883 2002-06-25
PCT/JP2003/002564 WO2003074702A1 (fr) 2002-03-06 2003-03-05 Nouvelle proteine et adn de celle-ci

Publications (1)

Publication Number Publication Date
ATE480621T1 true ATE480621T1 (de) 2010-09-15

Family

ID=27792043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03708492T ATE480621T1 (de) 2002-03-06 2003-03-05 Organische anionentransporter-proteine (oatp/lst) und ihre dna

Country Status (6)

Country Link
US (1) US7355001B2 (de)
EP (1) EP1482038B1 (de)
AT (1) ATE480621T1 (de)
AU (1) AU2003213389A1 (de)
DE (1) DE60334078D1 (de)
WO (1) WO2003074702A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1285084A1 (de) * 2000-01-25 2003-02-26 Hyseq, Inc. Neuartige nukleinsäure und polypeptide
US6972187B2 (en) * 2000-05-12 2005-12-06 Millennium Pharmaceuticals, Inc. OAT5 molecules and uses therefor

Also Published As

Publication number Publication date
AU2003213389A1 (en) 2003-09-16
WO2003074702A1 (fr) 2003-09-12
DE60334078D1 (de) 2010-10-21
EP1482038A4 (de) 2005-08-17
EP1482038A1 (de) 2004-12-01
US20050233323A1 (en) 2005-10-20
EP1482038B1 (de) 2010-09-08
US7355001B2 (en) 2008-04-08

Similar Documents

Publication Publication Date Title
CY1108046T1 (el) Μεθοδος για τον καθορισμο προπροϊνσουλινης
DK3085783T3 (da) Bispecifikt antistof som substitution for funktionelle proteiner
CY1115634T1 (el) Μεσα ανταγωνιστικης επιλεκτικης συνδεσης της πρωτεϊνης συνδεσης οστεοπροτεγερινης
BRPI0315652B8 (pt) molécula de ácido nucleico isolada, vetor, polipeptídeo de fusão, e, multímero
PL407889A1 (pl) Przeciwciało przeciwko receptorowi insulinopodobnego czynnika wzrostu I, zawierająca go kompozycja farmaceutyczna, sposób jego wytwarzania, zastosowania, linia komórkowa, wyizolowana cząsteczka kwasu nukleinowego, wektor, komórka gospodarza oraz zwierzę trangeniczne
PT911342E (pt) Nova proteina e processo para a produzir
WO2005007814A3 (en) Genome mapping of functional dna elements and cellular proteins
WO2005017205A3 (en) Nucleic acid mapping using linear analysis
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
ATE466080T1 (de) Formulierungen und verfahren zum denaturieren von proteinen
RS92704A (en) Immunoglobulin-domain containing cell surface recognition molecules
NO20043371L (no) Kortikotropinfrigjorendefaktorreseptor-2 agonister
DE60330489D1 (de) Schnell abgebaute reporter-fusionsproteine
DE60322727D1 (de) Rückgefaltetes Membranprotein in monodisperser Form
WO2005062947A3 (en) Methods and compositions for identifying rna-binding proteins
EP2083018A3 (de) Zusammensetzungen und Verfahren mit Bezug zu STOP-1
WO2004099388A3 (en) Cbl-b polypeptides, complexes and related methods
WO2003016551A3 (en) Novel salicylic acid-binding protein encoding nucleic acid, sabp2, and methods of use thereof
BRPI0407031A (pt) Composições e métodos para tratamento de câncer empregando igsf9 e liv-1
DE69942575D1 (de) Nukleinsäuremolekül, die für die alpha-kettedes pferde-fc-epsilon-rezeptors kodieren, korrespondierende proteine und ihre verwendungen
ATE480621T1 (de) Organische anionentransporter-proteine (oatp/lst) und ihre dna
DE602004016006D1 (de) Screening-verfahren
WO2005079316A3 (en) Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof
ATE556135T1 (de) Neues protein
DE60321443D1 (de) Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties